Dr. Figlin on Considerations for Combining TKIs and Immunotherapy in RCC OncLive 1:18 5 years ago 47 Далее Скачать
Dr. Figlin on Promise of Immunotherapy Plus TKI Combinations in RCC OncLive 1:32 5 years ago 78 Далее Скачать
Dr. Kim on Combining Immunotherapy and TKIs in Metastatic RCC OncLive 1:55 6 years ago 123 Далее Скачать
Dr. Figlin on Toxicity Profile of Immunotherapy/VEGF TKI Combinations in RCC OncLive 1:15 5 years ago 98 Далее Скачать
Robert A. Figlin, MD, considers combination I-O and TKIs indicated for the treatment of 1st line RCC OBRoncology 4:20 5 years ago 8 Далее Скачать
Dr. Figlin Discusses Sequencing mTOR Inhibitors and TKIs in RCC OncLive 1:44 11 years ago 267 Далее Скачать
Dr. Robert Figlin on The Increasingly Complicated Treatment Paradigm for Renal Cell Carcinoma Targeted Oncology 1:57 8 years ago 81 Далее Скачать
Dr. Figlin on Advances in Immunotherapy for Kidney Cancer OncLive 0:53 10 years ago 378 Далее Скачать
Dr. Robert Figlin on the Future of Treatment for Patients with RCC Targeted Oncology 1:38 9 years ago 126 Далее Скачать
Dr. Figlin Describes the Efficacy of AGS-003 in mRCC Targeted Oncology 1:12 10 years ago 60 Далее Скачать
Dr. Figlin Discusses the Future of Kidney Cancer Treatment OncLive 1:25 6 years ago 161 Далее Скачать
